Siegall is the chairman, ceo, and president of immunome, inc. Previously he was ceo of morphimmune, a privately held. Nearly one year after being ousted as ceo of seagen, clay siegall is back at the helm of a biotechnology company.
Nearly one year after being ousted as ceo of seagen, clay siegall is back at the helm of a biotechnology company. On thursday, he was named ceo and president of. Clay siegall is the president, chief executive officer and chairman of the board of immunome, inc. With a distinguished career in leadership and drug.
Clay siegall is the president, chief executive officer and chairman of the board of immunome, inc. With a distinguished career in leadership and drug.